Sara Bonstein Insmed Inc (INSM) insider trading activity

Sara Bonstein is Chief Financial Officer of INSMED Inc. Currently has a direct ownership of 84,017 shares of INSM, which is worth approximately $8.11 Million. The most recent transaction as insider was on Jul 07, 2025, when has been sold 57,764 shares (Common Stock) at a price of $95.93 per share, resulting in proceeds of $5,541,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84K

29.32% 3M change

28.48% 12M change

Total Value Held $8.11 Million

Sara Bonstein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 07 2025	SELL Open market or private sale	$5,541,300 $95.93 p/Share	57,764 Reduced 40.74%	84,017 Common Stock
Jul 07 2025	BUY Exercise of conversion of derivative security	$1,165,115 $24.33 p/Share	47,888 Added 25.25%	141,781 Common Stock
Jun 23 2025	SELL Open market or private sale	$5,887,986 $101.93 p/Share	57,765 Reduced 38.18%	93,536 Common Stock
Jun 23 2025	BUY Exercise of conversion of derivative security	$926,652 $19.35 p/Share	47,889 Added 24.04%	151,301 Common Stock
Jun 10 2025	SELL Open market or private sale	$5,168,324 $89.47 p/Share	57,766 Reduced 35.84%	103,412 Common Stock
Jun 10 2025	BUY Exercise of conversion of derivative security	$862,498 $18.01 p/Share	47,890 Added 22.91%	161,178 Common Stock
Jun 03 2025	SELL Open market or private sale	$112,898 $71.5 p/Share	1,579 Reduced 1.37%	113,288 Common Stock
May 15 2025	BUY Grant, award, or other acquisition	-	6,508 Added 5.36%	114,867 Common Stock
May 14 2025	SELL Open market or private sale	$107,206 $65.61 p/Share	1,634 Reduced 1.49%	108,359 Common Stock
May 13 2025	SELL Open market or private sale	$601,474 $67.81 p/Share	8,870 Reduced 7.46%	109,993 Common Stock
Feb 18 2025	SELL Open market or private sale	$1,477,486 $80.64 p/Share	18,322 Reduced 13.36%	118,863 Common Stock
Feb 12 2025	SELL Open market or private sale	$401,520 $80.0 p/Share	5,019 Reduced 3.53%	137,185 Common Stock
Feb 11 2025	SELL Open market or private sale	$1,064,160 $80.0 p/Share	13,302 Reduced 8.55%	142,204 Common Stock
Feb 06 2025	SELL Open market or private sale	$2,296,751 $80.9 p/Share	28,390 Reduced 15.44%	155,506 Common Stock
Feb 05 2025	BUY Grant, award, or other acquisition	-	65,033 Added 26.13%	183,896 Common Stock
Jan 10 2025	SELL Open market or private sale	$67,925 $63.72 p/Share	1,066 Reduced 0.89%	118,863 Common Stock
Jan 08 2025	SELL Open market or private sale	$96,697 $66.05 p/Share	1,464 Reduced 1.28%	113,272 Common Stock
Jan 08 2025	BUY Grant, award, or other acquisition	-	6,657 Added 5.26%	119,929 Common Stock
Jan 07 2025	SELL Open market or private sale	$227,979 $65.7 p/Share	3,470 Reduced 2.94%	114,736 Common Stock
May 29 2024	SELL Open market or private sale	$11,028,200 $50.0 p/Share	220,564 Reduced 65.25%	117,481 Common Stock
May 29 2024	BUY Exercise of conversion of derivative security	$5,792,010 $26.26 p/Share	220,564 Added 38.07%	358,769 Common Stock
May 28 2024	SELL Open market or private sale	$1,036,407 $50.01 p/Share	20,724 Reduced 5.78%	338,045 Common Stock
May 28 2024	BUY Exercise of conversion of derivative security	$544,212 $26.26 p/Share	20,724 Added 5.97%	326,613 Common Stock
May 14 2024	SELL Open market or private sale	$280,748 $25.32 p/Share	11,088 Reduced 8.62%	117,481 Common Stock
May 13 2024	BUY Grant, award, or other acquisition	-	14,518 Added 10.15%	128,569 Common Stock

Also insider at

SCPH

scPharmaceuticals Inc. Healthcare

XLO

Xilio Therapeutics, Inc. Healthcare

Sara Bonstein

Chief Financial Officer

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INSM shares.

Notify only if

Value

Insider Trading

Get notified when an Insmed Inc insider buys or sells INSM shares.

Notify only if

Operation

Value

Type

News

Receive news related to INSMED Inc

Track Activities on INSM

Account